Detalles de la búsqueda
1.
PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patients.
Inflammopharmacology
; 32(1): 433-446, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37477795
2.
Factors Associated With Mortality in Patients With Immune-Mediated Rheumatic Diseases and COVID-19 From Latin America: Data From Argentina, Mexico, and Brazil.
J Clin Rheumatol
; 30(1): e9-e17, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37936271
3.
Development of a Prediction Model for COVID-19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry.
ACR Open Rheumatol
; 4(10): 872-882, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35869686
4.
Guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases: a Brazilian Society of Rheumatology task force.
Adv Rheumatol
; 62(1): 3, 2022 01 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35039077
5.
Brazilian recommendations on the safety and effectiveness of the yellow fever vaccination in patients with chronic immune-mediated inflammatory diseases.
Adv Rheumatol
; 59(1): 17, 2019 04 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31036077
Resultados
1 -
5
de 5
1
Próxima >
>>